Rmc-4630 drug page Clinical trials

Trials with Rmc-4630

Every colorectal cancer trial that includes this drug. Those looking for patients come first.

2Trials
0Recruiting
10Countries
634Planned patients

Showing 1–2 of 2

Sotorasib Activity in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation (CodeBreak 101)
Ongoing, not recruiting Phase 1 610 patients NCT04185883

To evaluate the safety and tolerability of sotorasib administered in investigational regimens in adult participants with KRAS p.G12C mutant advanced solid tumors.

United States, Australia, Austria, Belgium and 6 more Dec 2019 – Dec 2027 Interventional
Combination Therapy of RMC-4630 and LY3214996 in Metastatic KRAS Mutant Cancers
Finished Phase 1 24 patients NCT04916236

This is a Phase I/Ib study in which the safety of the combination therapy of RMC-4630 and LY3214996 in the treatment of KRAS mutant cancers will be studied.

Netherlands Mar 2022 – Jul 2024 Interventional
Combined with: LY3214996